Scientific Advisory Panel

FuturaGene has formed a distinguished panel of scientific advisors who are internationally recognized for their expertise and invaluable contributions in plant biology, physiology and pathology as well as agronomy and genomics.

Michael E. Fromm, Ph.D.

Professor Oded Shoseyov


___________________________________________________________________________________________________

Michael E. Fromm, Ph.D.
Dr. Michael Fromm is the Director of the Plant Genome Center as well as Center for Biotechnology and Professor of Agronomy and Natural Resources at University of Nebraska in Lincoln, Nebraska (UNL), USA. Dr. Fromm received his B.Sc. in Chemistry from University of California at Davis, California and his Ph.D. in biochemistry and molecular biology from Stanford University, USA. Dr. Fromm has been the Director of the Metabolic Signaling Center since 2004. In addition to his many notable accomplishments, Dr. Fromm has also held several executive management positions in the business arena, including Panakos Pharmaceuticals, Mendel Biotechnology Inc. and Monsanto. It was while in Monsanto that Dr. Fromm initiated the company’s plant genomics program and headed the research team that developed the genetically-modified “Roundup Ready” corn and “YieldGard” corn, the Bt corn resistant to corn borers. Dr. Fromm’s research focuses on the long-term goal to understand the stress signaling pathway in sufficient detail to improve the drought and salt tolerance of plants.
Back to Top

Professor Oded Shoseyov
Prof. Shoseyov is a faculty member of the Hebrew University of Jerusalem. Prof. Shoseyov's research is in plant molecular biology and biotechnology. He has extensive experience with genetic engineering of plants, protein engineering and nano-biotechnology. He has authored or co-authored more than 100 scientific publications and is the inventor or co-inventor of 18 patents. Prof. Shoseyov received the Outstanding Scientist Polak Award for 2002, and the 1999 Kay Award for Innovative and Applied Research. He is the scientific founder of CBD Technolgies Ltd., co-founder of Fulcrum-SP Ltd., a nano-biotechnology company and Collplant Ltd., an agro-biotech company that produces human recombinant collagen in tobacco. He holds a Ph.D. from The Hebrew University of Jerusalem, Israel.
Back to Top